VRTX

Vertex Pharmaceuticals

Health Care

Biotechnology

Boston, Massachusetts

Last filing: Feb 13, 2026 (FY2025)

Balance Sheet 11 Accounts • 5 Years

Account	2025	2024	2023	2022	2021
BS_Assets_Cash	$0	$4.6B	$10.4B	$10.5B	$6.8B
BS_Assets_ShortTermInvest	$0	$36.6M	$46.0M	$116.8M	$230.9M
BS_Assets_Inventory	$0	$1.2B	$738.8M	$460.6M	$353.1M
BS_Assets_PPE	$0	$1.2B	$1.2B	$1.1B	$1.1B
BS_Assets_IntangibleAssets	$0	$825.9M	$839.9M	$603.6M	$400.0M
BS_Liab_AccruedLiab	$0	$2.8B	$2.7B	$2.1B	$1.7B
BS_Liab_OtherCurrent	$0	$363.0M	$527.2M	$311.5M	$268.4M
BS_Liab_OtherNoncurrent	$0	$901.8M	$877.7M	$685.8M	$116.8M
BS_Equity_PreferredStock	$0	$0	$0	$0	$0
BS_Equity_CommonStock	$0	$2.6M	$2.6M	$2.6M	$2.5M
BS_Equity_AOCI	$0	$127.8M	$-14.3M	$800.0K	$15.9M

Income Statement 18 Accounts • 5 Years

Account	2025	2024	2023	2022	2021
IS_Revenue_Total	$12.0B	$11.0B	$9.9B	$8.9B	$7.6B
IS_Expense_COGS	$1.7B	$1.5B	$1.3B	$1.1B	$904.2M
IS_Expense_RnD	$3.9B	$3.6B	$3.2B	$2.5B	$3.1B
IS_Expense_SGA	$1.8B	$1.5B	$1.1B	$944.7M	$840.1M
IS_Expense_DA	$209.8M	$207.2M	$181.3M	$148.3M	$125.6M
IS_Expense_SBC	$685.9M	$698.5M	$581.2M	$491.3M	$441.4M
IS_Expense_TotalOpex	$7.8B	$11.3B	$6.0B	$4.6B	$4.8B
IS_OperatingIncome	$4.2B	$-232.9M	$3.8B	$4.3B	$2.8B
IS_InterestExpense	$13.3M	$30.6M	$44.1M	$54.8M	$47.4M
IS_OtherNonopIncExp	$-7.7M	$-86.1M	$-22.8M	$-164.8M	$4.9M
IS_PreTaxIncome	$4.6B	$248.5M	$4.4B	$4.2B	$2.7B
IS_TaxExpense	$690.0M	$784.1M	$760.2M	$910.4M	$388.3M
IS_NetIncome	$4.0B	$-535.6M	$3.6B	$3.3B	$2.3B
IS_ComprehensiveIncome	$3.8B	$-393.5M	$3.6B	$3.3B	$2.4B
IS_EPS_Basic	$15	$-2	$14	$13	$9
IS_EPS_Diluted	$15	$-2	$14	$13	$9
IS_Shares_Basic	$255.7M	$257.9M	$257.7M	$256.1M	$257.7M
IS_Shares_Diluted	$258.0M	$257.9M	$260.5M	$259.1M	$259.9M

Cash Flow Statement 19 Accounts • 5 Years

Account	2025	2024	2023	2022	2021
CF_Ops_NetIncome	$4.0B	$-535.6M	$3.6B	$3.3B	$2.3B
CF_Ops_DA	$209.8M	$207.2M	$181.3M	$148.3M	$125.6M
CF_Ops_SBC	$685.9M	$698.5M	$581.2M	$491.3M	$441.4M
CF_Ops_DeferredTax	$-510.8M	$-348.8M	$-536.5M	$-275.9M	$-154.6M
CF_Ops_WorkingCapital	$1.3B	$2.2B	$1.0B	$942.2M	$491.2M
CF_Ops_Other	$148.5M	$39.7M	$208.9M	$498.9M	$16.8M
CF_Ops_NetCash	$3.6B	$-492.6M	$3.5B	$4.1B	$2.6B
CF_Inv_Capex	$437.6M	$297.7M	$200.4M	$204.7M	$235.0M
CF_Inv_PurchaseInvestments	$6.4B	$7.4B	$3.8B	$692.7M	$528.2M
CF_Inv_ProceedsInvestments	$5.9B	$4.5B	$839.1M	$920.0M	$499.3M
CF_Inv_Other	$24.7M	$54.0M	$31.0M	$47.8M	—
CF_Inv_NetCash	$-945.4M	$-3.8B	$-3.1B	$-321.1M	$-340.9M
CF_Fin_ShareRepurchases	$2.0B	$1.2B	$427.6M	$0	$1.4B
CF_Fin_StockIssuance	$55.6M	$50.0M	$80.8M	$144.6M	$64.2M
CF_Fin_TaxWithholding	$369.9M	$405.0M	$226.1M	$172.0M	$135.9M
CF_Fin_Other	$3.7M	$6.2M	$1.8M	$3.5M	$5.7M
CF_Fin_NetCash	$-2.3B	$-1.5B	$-562.2M	$-67.7M	$-1.5B
CF_FX_Effect	$90.9M	$-42.6M	$26.9M	$-29.2M	$-13.4M
CF_Net_Change	$515.6M	$-5.8B	$-139.7M	$3.7B	$811.2M

Stock Market Data (1 Year) Live Market Data

Price Data Unavailable

Stock price history for VRTX hasn't been loaded yet.

Recent Price History